Hyper IgM Defect

Introduction And Classification

Hyper-IgM syndromes are a heterogeneous group of primary immunodeficiency diseases characterized by a defect in immunoglobulin class switch recombination. Patients exhibit normal or elevated serum immunoglobulin M (IgM) with low or absent immunoglobulin G (IgG), immunoglobulin A (IgA), and immunoglobulin E (IgE).

Pathophysiology

• The immune defect depends on whether the genetic variant affects T-cell to B-cell crosstalk or intrinsic B-cell enzymatic processes.
  • CD40-CD40L Interaction Defects: CD40 ligand is normally expressed on activated CD4 T cells. It must interact with CD40 receptors on antigen-presenting cells, such as B cells, macrophages, and dendritic cells.
  • This interaction provides essential signals for B-cell isotype switching, somatic hypermutation, and the generation of memory B cells.
  • The signaling also stimulates macrophages to efficiently kill intracellular pathogens. Disruption results in a severe combined immunodeficiency phenotype.
  • Class Switch Enzyme Defects: Activation-induced cytidine deaminase (AID) and uracil DNA glycosylase (UNG) are enzymes exclusively required within the B cell for class switch recombination.
  • Defects in these enzymes are B-cell intrinsic, meaning T-cell helper functions and macrophage activation remain intact.

Clinical Manifestations

X-Linked (CD40L) And Autosomal Recessive CD40 Deficiency

These defects affect both humoral and cellular immunity, leading to early and severe clinical presentations.

• Recurrent pyogenic sinopulmonary infections typically begin in the first or second year of life.
• Patients show marked susceptibility to opportunistic infections, notably Pneumocystis jirovecii pneumonia (PJP).
• Cryptosporidium species frequently cause severe enteritis, which can progress to sclerosing cholangitis and subsequent liver failure.
• Chronic or recurrent neutropenia is a common and profound complication.
• There is a high risk of developing malignancies, particularly liver cancer, biliary tract cancer, and primitive neuroectodermal carcinomas, usually after the first decade of life.
• Mild clinical variants may uniquely present in adolescence with parvovirus-induced aplastic anemia.

Autosomal Recessive AID And UNG Deficiency

These defects are restricted to humoral immunity and present differently from the CD40/CD40L defects.

• Patients generally have an older age of onset and a more benign infectious course.
• Severe lymphoid hyperplasia with markedly enlarged lymph nodes and tonsils is a hallmark finding.
  • Biopsies show giant germinal centers filled with highly proliferating B cells.
• There is no increased susceptibility to Pneumocystis jirovecii or severe neutropenia.
• Patients exhibit a strong propensity for autoimmune and inflammatory diseases.
  • Common autoimmune manifestations include immune thrombocytopenia, hemolytic anemia, autoimmune hepatitis, inflammatory bowel disease, and polyarthritis.

Diagnosis And Laboratory Evaluation

Management

Supportive And Medical Therapy

• Lifelong immunoglobulin replacement therapy is the standard of care to prevent recurrent pyogenic infections.
• Aggressive treatment of documented infections with appropriate antimicrobial agents is crucial.
• Patients with CD40 or CD40L defects require strict lifelong Pneumocystis jirovecii prophylaxis using trimethoprim-sulfamethoxazole.
• Clean drinking water and strict hygiene precautions are necessary to prevent Cryptosporidium exposure.
• Granulocyte colony-stimulating factor (G-CSF) is beneficial for managing episodes of severe neutropenia.

Definitive Therapy

• Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for CD40 and CD40L deficiencies.
• HSCT is highly recommended at an early age before the onset of irreversible organ damage, sclerosing cholangitis, or malignancy.